Brief Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Jun 14, 2010; 16(22): 2812-2817
Published online Jun 14, 2010. doi: 10.3748/wjg.v16.i22.2812
Table 1 Clinical features of the study population n (%)
Clinical featuresPatient (n = 112)
Age (mean ± SD) (yr)59.67 ± 14.18
Sex
Male61 (54.5)
Female51 (45.5)
BMI, mean (SD) (kg/m2)23.26 (4.27)
DM status
DM27 (24.1)
Non-DM85 (75.9)
Disease leading to chronic renal failure
Chronic glomerulonephritis40 (35.7)
Primary hypertension31 (27.7)
Diabetes mellitus22 (19.6)
Polycystic kidney disease7 (6.2)
Gout3 (2.7)
Primary hypertension combined with gout3 (2.7)
Obstructive nephropathy2 (1.8)
Chronic interstitial nephritis1 (0.9)
Nephrotic syndrome1 (0.9)
Ischemic renal disease1 (0.9)
Microscopic Polyarteritis1 (0.9)
Steroid history
Yes8 (7.1)
No104 (92.9)
Daily dosage of pills, median (interquartile ranges)112.00 (6.00-21.25)
Predialytic GI symptoms
Yes14 (12.5)
No98 (87.5)
PD Duration, median (interquartile ranges) (mo)215.00 (8.00-33.00)
Type of PD
CAPD60 (53.6)
IPD50 (44.6)
Daily peritoneal dialysate volume (mean ± SD) (L)37.83 ± 1.28
Albumin (mean ± SD) (g/L)433.96 ± 4.77
Hemoglobin (mean ± SD) (g/L)5101.24 ± 20.06
Residual renal Kt/V, median (interquartile ranges)60.39 (0.00-0.82)
Peritoneal Kt/V (mean ± SD)61.51 ± 0.39
Total Kt/V (mean ± SD)62.00 ± 0.51